Crispr Therapeutics Viking Therapeutics: 2026 Stock Showdown
As biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
This introduction explains the core metrics an economic index tracks and how those measurements inform economic interpretation and planning.
17,569 articlesAs biotech investors look to 2026, crispr therapeutics viking therapeutics presents two distinct paths: gene editing ...
AI is redefining the CMO role, pushing marketing leaders toward broader corporate leadership. In 2026, budgets, gover...
With Senate leadership sidelined, key defense funding plans face delay as Iran tensions intensify and midterms loom. ...
Bitunix unveils a Visa-powered debit card allowing users to spend crypto worldwide and earn yields. The card integrat...
New Realtor.com analysis finds starter home inventory trails pre-pandemic levels by roughly 300,000 listings, with en...
Bill Gates manages a massive charitable portfolio with a striking concentration: about 30% of its value sits in a sin...
Snap once soared to a record high, but the stock now sits well below that peak. This article breaks down the recovery...
A high-stakes clash between Anthropic and the Pentagon nears a Friday deadline, drawing attention from markets and pe...
Syracuse reports a 30% drop in snow-complaint calls after deploying live GPS, dashcams, and AI. Officials say transpa...
Microsoft is doubling down on AI. This article lays out scenarios, risks, and concrete steps to understand where will...
Layoffs are being used to finance AI deployments as global AI expenditure rockets toward trillions. CEOs insist the ...
Stocks slip as growth signals and policy expectations shift in early 2026. This report outlines practical tips surviv...